Advanced BioDesign since its creation in 2010 has built its development on elaborating solutions for companies in the field of immunology through contracts of research dedicated to detection, evaluation and synthesis of low molecular weight metabolites and also of macromolecules. Recently, its R&D has been focused on infectiology and cancerology through discovery of biomarkers, with the first goal to deliver its infection diagnostic kit within two years, and the second goal to enter clinical phase I / IIa for its first anticancer drug.Read more
Advanced Biodesign offer solutions from the discovery of new antibody to the cell line development, through the evaluation of all critical steps in the evolution of your R&D projects. To do so we have developed “solutions”: a structured set of scientific and technologic skills included in independent “modules”. In the case of your therapeutics or biologics, we start our studies from its origin of discovery and creation at the preclinical research stage up to the clinical phase I. For each research project, a project manager is assigned to your study in an effective and interactive environment thus ensuring a long-term relationship with your research team.Read more
Based on our expertise in cancer metabolism and know-how in specific cell death called “apoptosis”, we will develop a new way to treat cancer to overcome actual stratification of cancer to bring new hope for patient. By focusing on rare or bad-prognostic cancer, Advanced BioDesign offer innovative therapy to target markets with high unmet medical needs in cancer.